Marcus A. Conant
Corporate Officer/Principal chez The University of California, San Francisco
Profil
Marcus A.
Conant is Chief Medical Officer of Presidio Pharmaceuticals, Inc., a Clinical Professor at the University of California, San Francisco, and Chairman of the Conant Foundation.
He was a Director of Enzo Biochem, Inc. Dr. Conant has 25 years of experience in treating HIV/AIDS patients.
He received a BS degree and an MD from Duke University.
Postes actifs de Marcus A. Conant
Sociétés | Poste | Début |
---|---|---|
The University of California, San Francisco | Corporate Officer/Principal | - |
Anciens postes connus de Marcus A. Conant
Sociétés | Poste | Fin |
---|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | - |
ENZO BIOCHEM, INC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ENZO BIOCHEM, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |